Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Disease area: Airway diseases, Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Nakata, T. Tanaka, R. Tazawa (Niigata, Japan). A mechanism for acceleration of GM-CSF autoantibody (GMAb) production in autoimmune pulmonary alveolar proteinosis (aPAP). Eur Respir J 2014; 44: Suppl. 58, 2024

Member's Comments

No comment yet.

Related content which might interest you: Pirfenidone suppresses proinflammatory and antiangiogenetic cytokine production by alveolar macrophages (AMs) in idiopathic non specific interstitial pneumonia (iNSIP) Source: International Congress 2014 – ILDs 2 Year: 2014 Mitochondrial tRNA gene mutations in patients with idiopathic pulmonary fibrosis (IPF) and sarcoidosis Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 Immunoproteasome expression in pulmonary fibrosis Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 Specific activation of non-classical Th1 cells in pulmonary sarcoidosis Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 Circulating monocytes from interstitial lung disease patients show an activated phenotype Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Molecular mechanisms of pirfenidone activity in human lung fibroblasts Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 Imbalance of M1/M2 alveolar macrophages phenotype in pulmonary sarcodosis Source: Annual Congress 2013 –Sarcoidosis Year: 2013 Imbalance of immune response functional phenotype and alveolar macrophages phenotype in COPD Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Pulmonary alveolar proteinosis (PAP) in exogenous toxic alveolitis (ETA) patients Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 Role of dendritic cells in pulmonary fibrosis in mice Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Anti-parietal cell autoimmunity in IPF patients Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Mitophagic regulation of myofibroblast differentiation in lung fibroblasts Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer Year: 2014 Functional phenotype of immune response and alveolar macrophages phenotype in pulmonary sarcoidosis Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Effect of nintedanib on the release of angiogenic/angiostatic cytokines by alveolar macrophages (AMs) in interstitial lung diseases (ILD) Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Usefulness of a myositis antibody immunoblot in diagnosis of connective tissue disease (CTD) related interstitial lung disease (ILD) Source: International Congress 2014 – ILDs 4 Year: 2014 Lipoxin (LXA4) as a novel therapy for idiopathic pulmonary fibrosis Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Early effect of whole lung lavage (WLL) on surfactant homeostasis in pulmonary alveolar proteinosis (PAP) Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations Year: 2014 Macrophage migration inhibition factor in peripheral blood and induced sputum in patients with COPD Source: International Congress 2014 – Basic and translational research in asthma and COPD Year: 2014 MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP) Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013